Brian Koopman - 10 Oct 2022 Form 4 Insider Report for UTAH MEDICAL PRODUCTS INC (UTMD)

Role
Principal Financial Officer
Signature
/s/ Brian L. Koopman
Issuer symbol
UTMD
Transactions as of
10 Oct 2022
Net transactions value
$0
Form type
4
Filing time
25 Oct 2022, 19:39:50 UTC
Previous filing
28 Oct 2021
Next filing
03 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTMD Employee Stock Option - Right to Buy Award $0 +1,000 +28% $0.000000 4,600 24 Oct 2022 Common Stock 1,000 $82.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option will vest 25% on 10/01/2023, and at an additional 6.25% on 01/01/2024 and the first day of each calendar quarter thereafter. Fully exercisable on 10/01/2026.